Cargando…
Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no medical treatment proven to improve survival and postpone liver transplantation. Previous studies have shown the effectiveness of fibrates in primary biliary cholangitis. The current study prospectively evaluated the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277608/ https://www.ncbi.nlm.nih.gov/pubmed/35822553 http://dx.doi.org/10.1002/prp2.984 |